Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
Time allocation may not decrease with price for a non-linear microscopic utility of leisure.
Published 2014“…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”
-
71
Elevated PE level in yeast decreases the sensitivity of replicating tombusvirus RNA to the reconstituted RNAi.
Published 2017“…Bottom panel: Immuno-blot detection of affinity-purified FLAG-AGO1 with anti-FLAG antibody in samples used in the in vitro slicing assay above. (E) Decreased sensitivity of viral dsRNA products to MNase treatment (0.05 U/μl) in the <i>cho2Δ</i> CFE-based TBSV replication assay. …”
-
72
-
73
-
74
Measurements of HO-1 and dephosphorylated p38-MAPK concentrations in alveolar macrophages.
Published 2015Subjects: -
75
-
76
-
77
-
78
Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ<sub>m</sub> decrease.
Published 2013“…<p>(<b>A, B</b>) HBMEC (<b>A</b>) and Caco-2 cells (<b>B</b>) were incubated for the times indicated with EHEC-Hly-containing OMVs TA50 or 8033 (20 µg of OMV protein containing 100 ng of EHEC-Hly) or with corresponding protein amounts of EHEC-Hly-negative OMVs TA51 or 8033c or left untreated (control). …”
-
79
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
80